Eli Lilly’s Q4 revenue surges 8% to $ 7.9 billion

Eli Lilly and Co. announced on Thursday that its revenue in the fourth fiscal quarter increased 8% to stand at $ 7.9 billion. Excluding revenue from COVID-19 therapies, the firm’s revenue increase…